Evidence map›Paper›PMID 30086727›Full record

ArticleBMC cancer2018

Liver cancer mortality trends in South Africa: 1999-2015.

Daniel Mak, Mazvita Sengayi, Wenlong C Chen, Chantal Babb de Villiers, Elvira Singh, Anna Kramvis

Abstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Identification ofFrontiers in molecular biosciences · 2025
    Article
  3. Article
  4. Review
  5. Modeling the Trend Changes of Liver Cancer Mortality in the 6 WHO Regions.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel MakHepatitis Virus Diversity Research Unit (HVDRU), Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Mazvita SengayiNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Wenlong C ChenNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Chantal Babb de VilliersDivision of Human Genetics, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Elvira SinghNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa. Elvira.Singh@nhls.ac.za.
Anna KramvisHepatitis Virus Diversity Research Unit (HVDRU), Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Anna.Kramvis@wits.ac.za.ORCID http://orcid.org/0000-0001-6006-3765

Funding

Deutsche Forschungsgemeinschaft GL 595/3-1
6 · The paper itself

Abstract

backgroundIn South Africa (SA), liver cancer (LC) is a public health problem and information is limited.

methodsJoinpoint regression analysis was computed for the most recent LC mortality data from Statistics South Africa (StatsSA), by age group, sex and population group. The mortality-to-incidence ratios (MIRs) were calculated as the age-adjusted mortality rate divided by the age-adjusted incidence rate.

resultsFrom 1999 to 2015, the overall LC mortality significantly decreased in men (- 4.9%) and women (- 2.7%). Overall a significant decrease was noted in black African men aged 20-29 and 40-49 years, and white women older than 60 years but mortality rates increased among 50-59 and 60-69 year old black African men (from 2010/2009-2015) and women (from 2004/2009-2015). The mortality rates increased with age, and were higher among blacks Africans compared to whites in all age groups - with a peak black African-to-white mortality rate ratio of six in men and three in women at ages 30-39 years. The average MIR for black African men and women was 4 and 3.3 respectively, and 2.2 and 1.8 in their white counterparts. Moreover, decreasing LC mortality rates among younger and the increase in rates in older black Africans suggest that the nadir of the disease may be near or may have passed.

conclusionsFindings of population-age subgroup variations in LC mortality and the number of underdiagnosed cases can inform surveillance efforts, while more extensive investigations of the aetiological risk factors are needed. IMPACT: There was a large race, sex and age differences in trends of LC mortality in SA. These findings should inform more extensive evaluation of the aetiology and risk factors of LC in the country in order to guide control efforts.

Indexed as

AdultAgedBlack PeopleCohort StudiesFemaleHumansIncidenceLiver NeoplasmsMaleMiddle AgedSouth AfricaWhite PeopleYoung AdultIncidenceLiver cancerMortalitySouth AfricaSub-Saharan AfricaTrends

Identifiers

PMID30086727
PMCPMC6081797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.